Growth of human immunodeficiency virus (HIV) after infection requires the integration of a DNA copy of the viral RNA genome into a chromosome of the host. Here we present a simple in vitro system that carries out the integration reaction and the use of this system to probe the mechanism of integration. The only HIV protein necessary is the integration (IN) protein, which has been overexpressed in insect cells and then partially purified. DNA substrates are supplied as oligonucleotides that match the termini of the linear DNA product of reverse transcription. In the presence of HIV IN protein, oligonucleotide substrates are cleaved to generate the recessed 3' ends that are the precursor for integration, and the cleaved molecules are efficiently inserted into a DNA target. Analysis of reaction products reveals that HIV IN protein joins 3' ends of the viral DNA to 5' ends of cuts made by IN protein in the DNA target. We have also used this assay to characterize the sequences at the ends of the viral DNA involved in integration. The assay provides a simple screen for testing candidate inhibitors of HIV IN protein; some such inhibitors might have useful antiviral activity.
ABSTRACT
Growth of human immunodeficiency virus (HIV) after infection requires the integration of a DNA copy of the viral RNA genome into a chromosome of the host. Here we present a simple in vitro system that carries out the integration reaction and the use of this system to probe the mechanism of integration. The only HIV protein necessary is the integration (IN) protein, which has been overexpressed in insect cells and then partially purified. DNA substrates are supplied as oligonucleotides that match the termini of the linear DNA product of reverse transcription. In the presence of HIV IN protein, oligonucleotide substrates are cleaved to generate the recessed 3' ends that are the precursor for integration, and the cleaved molecules are efficiently inserted into a DNA target. Analysis of reaction products reveals that HIV IN protein joins 3' ends of the viral DNA to 5' ends of cuts made by IN protein in the DNA target. We have also used this assay to characterize the sequences at the ends of the viral DNA involved in integration. The assay provides a simple screen for testing candidate inhibitors of HIV IN protein; some such inhibitors might have useful antiviral activity.
Growth of a retrovirus after infection of a permissive cell requires establishment of the proviral state. Early after infection, reverse transcriptase synthesizes a DNA copy of the viral RNA genome, which is subsequently integrated into a chromosome of the host cell. The viral integration (IN) protein is required for this integration reaction (refs. 1-5 ; for recent reviews, see refs. 6 and 7). Circular and linear forms of the viral DNA are found in cells after infection, but only the linear form appears to be integrated (8) (9) (10) .
Studies of Moloney murine leukemia virus (MoMLV) and avian sarcoma-leukosis virus (ASLV) have delineated the DNA cleavage and strand transfer reactions that mediate integration. The blunt ends of the linear product of reverse transcription are first cleaved to remove two bases from each 3' end. The IN protein of MoMLV is required for this cleavage in vivo (11) , and the IN proteins ofMoMLV and ASLV carry out this reaction in vitro (12) (13) (14) . After this first cleavage reaction, a DNA strand transfer step joins each 3' each of the viral DNA to the protruding 5' ends ofa staggered break in the DNA target (8, 9) . The IN proteins of MoMLV and ASLV carry out the strand transfer reaction in vitro (12, 15) . The single-stranded connections between the ends of the viral and host DNAs are then converted to double-strand joints, presumably by cellular DNA repair enzymes, to yield the integrated provirus.
As a first step toward developing a fully defined system that carries out integration of human immunodeficiency virus (HIV) DNA, we partially purified HIV IN protein from insect cells expressing a cloned copy of the IN coding region. A low level of correct DNA integration was detected in vitro in the presence of this IN protein fraction by a genetic assay that monitored integration of a model substrate DNA into ADNA (16) . The model substrate, termed miniHIV, was a linear DNA molecule with ends that resemble those of unintegrated HIV DNA following the cleavage step; thus only the subsequent DNA strand transfer step of integration was assayed.
Here we report a simple and more efficient assay for both the long terminal repeat (LTR) cleavage and DNA strand transfer activities of HIV IN protein and the use of this assay in dissecting the mechanism of HIV DNA integration. Sherman and Fyfe have also reported a specific LTR cleavage activity of HIV IN protein (17) .
MATERIALS AND METHODS
Partial Purification of Soluble HIV IN Protein. Overexpression and partial purification of insoluble HIV IN protein have been described (16) . The HIV IN-containing insoluble fraction from two 150-cm2 tissue culture flasks, prepared as described (16) , was solubilized in a buffer containing 4 M urea, fractionated on a Superose 12 column, and dialyzed to remove the urea exactly as described for MoMLV IN protein (12) . HIV IN protein was the predominant species in the preparation as determined by Coomassie blue staining of SDS/PAGE gels. The concentration of HIV IN protein was estimated by comparison to bovine serum albumin standards.
loxP-cre Recombination. The 174-base-pair (bp) circular DNA target was prepared by recombination of plasmid pAB253 (18) in the presence of the Cre protein of bacteriophage P1. Cre protein was kindly provided by Andrew Bates (University of Leicester). Reactions were carried out as described (19) . One-hundred seventy-four-base-pair circular DNA products were isolated on a native polyacrylamide gel, eluted from the gel slice, and purified by chromatography on a G-25 Sephadex column.
LTR Cleavage and Insertion Assays. Reaction mixtures (16 Al) contained 25 mM KCI, 50 mM potassium glutamate, 10 mM 2-mercaptoethanol, 30 mM Mes (pH 6.2), 15 mM MnCl2, 10% glycerol, 100 pug of bovine serum albumin per ml, 0.3 pmol of labeled duplex LTR DNA, and -10 pmol of HIV IN protein. Reaction mixtures were incubated for 1 hr at 30'C. End labeling and hybridization of complementary strands of oligonucleotide substrates were carried out as described (12) . Analysis of reaction products on DNA sequencing gels was conducted as described (12) . Preparative reaction mixtures for characterization of LTR insertion products were scaled up 4-fold, and the products of four such reactions were gel isolated and eluted from the gel slice by the crush-soak method (20) . Aliquots were then cleaved by the MaxamGilbert chemical sequencing method (21) . Assays of insertion of LTR substrates into a heterologous target were as above except 40 fmol of the 174-bp circular DNA was added to each reaction mixture, the incubation temperature was increased Abbreviations: HIV, human immunodeficiency virus; LTR, long terminal repeat; MoMLV, Moloney murine leukemia virus.
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to 370C, and the incubation time was increased to 2 hr. Reaction products were separated on 5% native polyacrylamide gels in TBE buffer (20) and visualized by autoradiography. To determine whether HIV IN protein can specifically cleave the termini of the unintegrated linear viral DNA, oligonucleotides matching the LTR sequences at the predicted left (U3) and right (U5) ends of the unintegrated HIV DNA (22, 23) were prepared and assayed in vitro ( Fig. 1 ; LTR A and LTR B). Oligonucleotide LTR substrates were labeled on the 5' end of the DNA strand expected to be cleaved by IN protein (the bottom strand as shown in Fig. 1 ). Reaction products were separated by electrophoresis on a denaturing polyacrylamide gel and visualized by autoradiography ( grams such as those presented in Fig. 2A reveal the presence of products resembling those expected for proper strand transfer. A "ladder" of labeled bands of higher molecular weight than the unreacted substrate is seen with LTR A and LTR B that terminates at a length approximately twice that of two substrate molecules (Fig. 2B, lane 4 ofeach panel) . No such products are detectable when the HIV IN fraction is replaced by a control fraction from insect cells infected with a wild-type baculovirus (lane 3 of each panel). The lower molecular weight DNA products expected from the strand transfer reaction are also detected. Some low molecular weight products are also seen with control reactions and are probably products of cleavage by contaminating cellular nucleases.
RESULTS
Characterization ofInsertion Products. The ladder oflonger DNA products made in reaction mixtures containing HIV IN protein was analyzed to determine whether these DNAs have the structure expected of authentic strand transfer products. DNA from the upper two-thirds of a product ladder was purified from a gel, and aliquots were cleaved by the MaxamGilbert chemical sequencing method. The resulting chemical cleavage products were visualized by autoradiography after electrophoresis on a denaturing gel (Fig. 2C) . The scheme shown in Fig. 3A predicts that the sequence should be that of the LTR substrate up to the 3' A residue at the site ofcleavage by IN protein. Beyond this position, a labeled band should be seen in all lanes, since the cleaved LTR DNA is inserted adjacent to different target bases in different product molecules. The sequence of reaction products shown in Fig. 2C exactly matches that expected.
Effects of Modifications of the LTR Substrate. To ask whether LTR cleavage by IN protein itself is required for the subsequent strand transfer reaction, a substrate with a recessed 3' end resembling the product of cleavage by IN was assayed (LTR C; Fig. 1 ). Fig. 2B shows that the higher molecular weight product ladder was also obtained with this substrate. In fact, LTR C is reproducibly more active than LTR A, the matching blunt-ended substrate, which requires cleavage before strand transfer.
The importance of the distance between the A residue at the site of cleavage (position 3 in the bottom strand) and the proximal LTR end was examined by analyzing LTR D and LTR E (Fig. 1) . These substrates contain 3 bp (LTR D) or 1 bp (LTR E) 3' of the A, instead of the usual 2 bp (LTR A). LTR D and LTR E were cleaved adjacent to the correct A residue and then inserted into target DNA, indicating that the internal sequence, rather than the distance from the proximal DNA end, primarily dictates the position of cleavage (data not shown, summarized in Fig. 1) .
The internal LTR sequences required for LTR cleavage and strand transfer were mapped by analyzing the activity of LTR substrates containing base substitutions. The A residue at position 3 on the bottom strand is conserved in all retroviruses sequenced and is important for integration in the MoMLV system in vitro (12, 26) . The importance of this A residue in the HIV system was tested with LTR F, a LTR substrate in which the conserved A residue is changed to G. No specific cleavage or DNA insertion was detected (Fig. 1) . Substitution of bases 4-9 with a recognition site for the enzyme SnaBI (LTR G) abolished detectable cleavage and strand transfer, but replacing bases 10-15 (LTR H) or bases 16-21 (LTR I) with the SnaBI site had no obvious effect on the efficiency of cleavage and strand transfer (Fig. 1) .
Insertion into a Heterologous DNA Target. To determine whether the strand transfer products detected in these experiments result primarily from insertion of single LTR substrate molecules or concerted insertion of pairs of LTR substrates, a 174-bp circular DNA was tested as a target in the in vitro assay. A new labeled product was detected in reaction mixtures containing a 5' labeled LTR substrate, the circular target DNA, and partially purified HIV IN protein after Fig. 1 . The sequence of this addition was 5'-GGATCCTATCG-3' and its complement. The use of the 174-bp circular target, synthesized using the loxP-cre recombination system of phage P1, and this lengthened LTR substrate facilitated subsequent characterization of reaction products after denaturation (see text).
A B p p--A, A p electrophoresis on a native polyacrylamide gel and autoradiography (Fig. 4, lane 1) . (Fig. 3B) . In support of this view, it was found that reaction mixtures containing 404-bp or 2686-bp circular target DNAs yield products comigrating with the relaxed circular forms of these target DNAs (data not shown). The labeled linear product resulting from concerted integration of pairs of LTR substrates was not detected in these experi-
To further analyze the structure of the putative tagged circle DNA, this product was excised from a gel, denatured in formamide, and analyzed by electrophoresis on a denaturing gel (data not shown). A labeled species migrating slightly more slowly than a 201-base marker was observed, the size expected for the labeled strand of the tagged circle.
The U3 and U5 Ends of the HIV LTR Are Functionally Distinct. The U5 end of the HIV LTR (LTR B) was reproducibly more active in assays of LTR cleavage and strand transfer than was the U3 end (LTR A). To characterize this difference further, the activities of the U3 and U5 ends were compared in a competition experiment. Equal amounts of each LTR DNA were added to reaction mixtures containing the 174-bp circular DNA target, and the products were analyzed by autoradiography after prolonged electrophoresis on a 38-cm native polyacrylamide gel. The signals corresponding to insertion of the U3 or U5 ends were distinguished by varying the lengths of the U3 and U5 substrates. To verify that the two signals could be adequately resolved in a single gel lane, the products of separate reaction mixtures containing a 32-bp U5 LTR and a 21-bp U3 LTR (Fig. 5, lane 3) (27, 28 of HIV DNA into target DNA. The sequencing of strand transfer products generated in vitro indicates that a 3' end of the LTR is linked to a 5' end in the DNA target. The 5' end of the LTR remains unlinked in this intermediate (unpublished data). The 3' LTR end that becomes linked to target DNA is inferred to have a 3' OH and not a 3' phosphate by (i) the electrophoretic mobility of the product of cleavage by IN protein and (ii) the observation that a "precleaved" substrate synthesized with a 3' OH (LTR C) is efficiently inserted into target DNA. HIV thus appears to be a member of the large family of DNA insertion elements, including MoMLV, TyJ, phage Mu, and TnJO, that join terminal 3' OH ends of the element to the 5' ends of a cut made in the target DNA (8, 9, (29) (30) (31) .
The finding that a precleaved substrate, LTR C, can be properly integrated establishes that the cleavage of the LTR ends is not energetically coupled to insertion ofthis DNA into target DNA. The energy of the phosphodiester bond broken in the LTR cleavage reaction cannot be stored and used for the subsequent strand transfer reaction. Because there is also no requirement for a high-energy cofactor, it seems probable that the energy for strand transfer derives from phosphodiester bonds broken in the target DNA during the reaction.
We find that sequences near the end of the LTR DNA are required for function of HIV IN protein, but the relation of these sequences to the proximal DNA end is not strictly fixed. The critical bases required for function of HIV IN protein apparently lie between positions 2 and 9, since LTR substrates containing base substitutions in this region are drastically impaired in LTR cleavage and DNA strand transfer. The importance of this region is also highlighted by the observation that sequences of the 9 terminal bp are more conserved between HIV isolates than the sequence of the LTR as a whole (32) . The exact spacing between the proximal 3' end of the LTR and base pairs 2-9 is not critical: addition or subtraction of a base pair at the proximal 3' end does not eliminate cleavage at the proper A residue (position 3 in Fig.  1 ) or subsequent strand transfer. The MoMLV IN protein also requires sequences of the MoMLV LTR in the corresponding region for function. In addition to the internal sequences, function of MoMLV IN protein seems to require the presence of a DNA end roughly 2-5 bases from the A residue at the site of cleavage (11, 26, 33) . A similar flexible requirement for a nearby DNA end may also apply for the HIV case.
The ends of the unintegrated HIV DNA are functionally distinct: the U5 end is more active in competition assays than the U3 end. The difference in function reflects the difference in sequence at the two ends, which match at only 8 of the 13 terminal bp. The U3 and U5 ends of MoMLV DNA, in contrast, match at all 13 terminal bp. The sequence of the U3 region of HIV may represent a compromise between competing requirements not present in MoMLV: in addition to its role in integration, the U3 region of HIV encodes part of the Nef protein (24, 25) , whereas the U3 region of MoMLV does not encode any known proteins. The sequence of U3 of HIV may be constrained by both the integration and coding requirements and so may not be optimized for integration alone.
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